| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.039 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |